Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [406]

Researchers unveil the origin of second paediatric cancers and chemotherapy-induced mutations in healthy tissues

Researchers unveil the origin of second paediatric cancers and chemotherapy-induced mutations in healthy tissues

New assay identifies clinically relevant gene fusions in paediatric tumours more accurately and efficiently

New assay identifies clinically relevant gene fusions in paediatric tumours more accurately and efficiently

Immunotherapy before surgery leads to promising long-term survival in sarcoma patients

Immunotherapy before surgery leads to promising long-term survival in sarcoma patients

A newly developed therapeutic strategy offers potential in treating neurofibromatosis type 1 skin tumours

A newly developed therapeutic strategy offers potential in treating neurofibromatosis type 1 skin tumours

AI driven drug discovery company nominates preclinical candidate for the treatment of advanced solid tumours targeting the mitotic kinesin KIF18A

AI driven drug discovery company nominates preclinical candidate for the treatment of advanced solid tumours...

The roles of USP1 in Ewing sarcoma

The roles of USP1 in Ewing sarcoma

In judo move, scientists use cancer's strength to fight against it

In judo move, scientists use cancer's strength to fight against it

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma

PROX1/α-SMA correlated with colorectal cancer progression, poor outcomes and therapeutic resistance

PROX1/α-SMA correlated with colorectal cancer progression, poor outcomes and therapeutic resistance

First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase I first-in-human clinical trial

First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase I first-in-human clinical trial

More from ecancer